New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

Clinical trial NCT01482104 · COMPLETED

Trial details

NCT number: NCT01482104
Sponsor: Norwegian University of Science and Technology
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Skin Neoplasms Carcinoma, Basal Cell

Start date: 2012-06-01
Primary completion: 2017-10-01
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.